stockrowNovanta Inc.
NOVT Technology Scientific & Technical Instruments
Novanta Inc.’s revenue for fiscal 2025 (year ended December 2025) was $980.6 million, up 3.30% from fiscal 2024.
- Revenue
- +10.3%
- EPS
- +158.3%
- Free cash flow
- +391.8%
- Total debt
- −50.0%
Quarter to June 2026, against a year earlier
Follow NOVT
Alert me
Novanta Inc. (NOVT) EPS (diluted)
Novanta Inc.'s EPS (diluted) for fiscal 2025 was $1.47, down 16.9% from $1.77 in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.56. Over the past ten years it has ranged from $0.63 (fiscal 2016) to $2.06 (fiscal 2022); the current reading is higher than 73% of that period. EPS (diluted) has fallen for 3 consecutive fiscal years. Novanta Inc. ranks 13th of 32 Scientific & Technical Instruments companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $1.47 | (16.95%) |
| FY2024 | $1.77 | (12.38%) |
| FY2023 | $2.02 | (1.94%) |
| FY2022 | $2.06 | 46.10% |
| FY2021 | $1.41 | 12.80% |
| FY2020 | $1.25 | 8.70% |
| FY2019 | $1.15 | (19.58%) |
| FY2018 | $1.43 | 26.55% |
| FY2017 | $1.13 | 79.37% |
| FY2016 | $0.63 | (38.24%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $0.30 | (41.18%) |
| Mar 2026 | $0.51 | 13.33% |
| Dec 2025 | $0.45 | 50.00% |
| Sep 2025 | $0.30 | 150.00% |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| ESE ESCO Technologies Inc. compare | $12.14 |
| MKSI MKS Inc. compare | $6.27 |
| ITRI Itron, Inc. compare | $6.18 |
| BMI Badger Meter, Inc. compare | $4.33 |
| ST Sensata Technologies Holding N.V. compare | $2.50 |
| VNT Vontier Corporation compare | $2.41 |
| NOVT Novanta Inc. | $1.56 |
| CGNX Cognex Corporation compare | $1.03 |
| TRMB Trimble Inc. compare | −$0.49 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on NOVT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement